Dermatological Reviews, 5 (5)
PBAC advice on equitable access to GLP-1 obesity treatments. Diabetes Australia
Aqua/Water/Eau, Butylene Glycol, Glycerin, Bis-Peg-18 Methyl Ether Dimethyl Silane, Aluminum Starch Octenylsuccinate, Sodium Polyacrylate, Bambusa Arundinacea Stem Extract, Polysorbate 80, Phenoxyethanol, Polymethylsilsesquioxane, Tocopheryl Acetate, Panthenol, Salvia Hispanica Seed Extract, Disodium Edta, Parfum/Fragrance, Linalool, Ascorbyl Glucoside, Peg-8, Lactobacillus Ferment, Tocopherol, Sodium Hyaluronate, Lecithin, Alcohol Denat., Geraniol, Pantolactone, Bht, Ascorbyl Palmitate, Citronellol, Camellia Sinensis Leaf Extract, Coffea Arabica (Coffee) Seed Extract, Pongamia Pinnata Seed Extract, Benzyl Benzoate, Limonene, Angelica Archangelica Root Extract, Citrus Aurantium Amara (Bitter Orange) Peel Extract, Maltodextrin, Citric Acid, Magnesium Aluminum Silicate, Xanthan Gum, Ascorbic Acid, Caprylyl Glycol, Sclerotium Gum, Sorbic Acid, Fd&Amp;C Yellow No
Vial vs
One of the methods is by the use of an oral dispersible film made of hydroxypropyl cellulose (HPC), which is a nontoxic substance widely used in the pharmaceutical industry for diverse applications
Sahebkar A, Foroutan Z, Katsiki N, Jamialahmadi T, Mantzoros CS
